Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Retrospective Study Investigating Maintenance Therapy with Dasatinib in Patients with Chronic Myeloid Leukemia

Trial Profile

A Retrospective Study Investigating Maintenance Therapy with Dasatinib in Patients with Chronic Myeloid Leukemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2018

At a glance

  • Drugs Dasatinib (Primary)
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2018 New trial record
    • 17 Jun 2018 Results of a retrospective study assessing maintenance therapy with dasatinib every other day in CP-CML patients along with the results of a prospective maintenance study which is a part of OPTIM dasatinib trial, presented at the 23rd Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top